Cassader M - Search Results

1

Six months of resveratrol supplementation has no measurable effect in type 2 diabetic patients. A randomized, double blind, placebo-controlled trial.

Bo S, Ponzo V, Ciccone G, Evangelista A, Saba F, Goitre I, Procopio M, Pagano GF, Cassader M, Gambino R. Bo S, et al. Among authors: cassader m. Pharmacol Res. 2016 Sep;111:896-905. doi: 10.1016/j.phrs.2016.08.010. Epub 2016 Aug 9. Pharmacol Res. 2016. PMID: 27520400 Free article. Clinical Trial.

2

[Role of insulin receptors in the pathogenesis and treatment of diabetes].

Lenti G, Pagano G, Cassader M. Lenti G, et al. Among authors: cassader m. Journ Annu Diabetol Hotel Dieu. 1978:73-86. Journ Annu Diabetol Hotel Dieu. 1978. PMID: 349230 French. No abstract available.

3

Insulin binding to target cells (general survey, problems and results in spontaneous obesity).

Pagano G, Cassader M. Pagano G, et al. Among authors: cassader m. Ric Clin Lab. 1979 Apr-Jun;9(2):115-27. Ric Clin Lab. 1979. PMID: 504897

4

[Insulin resistance in spontaneous obesity. Role of insulin receptors].

Pagano G, Cassader M. Pagano G, et al. Among authors: cassader m. Minerva Dietol Gastroenterol. 1979 Jul-Sep;25(3):265-74. Minerva Dietol Gastroenterol. 1979. PMID: 554018 Italian. No abstract available.

5

Insulin receptors in adipocytes of non-diabetic and diabetic subjects. Preliminary report.

Pagano G, Cassader M, Lenti G. Pagano G, et al. Among authors: cassader m. Acta Diabetol Lat. 1977 May-Aug;14(3-4):164-9. doi: 10.1007/BF02581404. Acta Diabetol Lat. 1977. PMID: 605746

6

Comparison of the effects of bezafibrate and acipimox on the lipid pattern and plasma fibrinogen in hyperlipidaemic type 2 (non-insulin-dependent) diabetic patients.

Niort G, Cassader M, Gambino R, Pagano G. Niort G, et al. Among authors: cassader m. Diabete Metab. 1992 May-Jun;18(3):221-8. Diabete Metab. 1992. PMID: 1397477 Clinical Trial.

7

The glucoregulatory and antilipolytic actions of insulin in abdominal obesity with normal or impaired glucose tolerance: an in vivo and in vitro study.

Cavallo-Perin P, Bruno A, Cassader M, Cesco L, Gruden G, Pagano G. Cavallo-Perin P, et al. Among authors: cassader m. Eur J Clin Invest. 1992 Nov;22(11):725-31. doi: 10.1111/j.1365-2362.1992.tb01436.x. Eur J Clin Invest. 1992. PMID: 1478241

8

Lipoprotein-apolipoprotein changes in renal transplant recipients: a 2-year follow-up.

Cassader M, Ruiu G, Gambino R, Alemanno N, Triolo G, Pagano G. Cassader M, et al. Metabolism. 1991 Sep;40(9):922-5. doi: 10.1016/0026-0495(91)90067-7. Metabolism. 1991. PMID: 1895957

9

Lipoprotein and apoprotein levels in different types of dialysis.

Cassader M, Ruiu G, Tagliaferro V, Triolo G, Pagano G. Cassader M, et al. Int J Artif Organs. 1989 Jul;12(7):433-8. Int J Artif Organs. 1989. PMID: 2767788

10

Insulin resistance in Graves' disease: a quantitative in-vivo evaluation.

Cavallo-Perin P, Bruno A, Boine L, Cassader M, Lenti G, Pagano G. Cavallo-Perin P, et al. Among authors: cassader m. Eur J Clin Invest. 1988 Dec;18(6):607-13. doi: 10.1111/j.1365-2362.1988.tb01275.x. Eur J Clin Invest. 1988. PMID: 3147186 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

198 results

Search Page

Filters